VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 48 filers reported holding VOYAGER THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $7,178,000 | +103.6% | 375,000 | 0.0% | 0.02% | +80.0% |
| Q4 2018 | $3,525,000 | -50.3% | 375,000 | 0.0% | 0.01% | -37.5% |
| Q3 2018 | $7,095,000 | -23.6% | 375,000 | -21.1% | 0.02% | -23.8% |
| Q2 2018 | $9,282,000 | +4.0% | 475,000 | 0.0% | 0.02% | 0.0% |
| Q1 2018 | $8,925,000 | -17.9% | 475,000 | -27.5% | 0.02% | -16.0% |
| Q4 2017 | $10,873,000 | -45.8% | 655,000 | -32.8% | 0.02% | -49.0% |
| Q3 2017 | $20,075,000 | +124.1% | 975,000 | -2.5% | 0.05% | +122.7% |
| Q2 2017 | $8,960,000 | -32.3% | 1,000,000 | 0.0% | 0.02% | -33.3% |
| Q1 2017 | $13,240,000 | +133.0% | 1,000,000 | +124.2% | 0.03% | +106.2% |
| Q4 2016 | $5,683,000 | +136.6% | 446,080 | +123.0% | 0.02% | +128.6% |
| Q3 2016 | $2,402,000 | +118.6% | 200,000 | +100.0% | 0.01% | +133.3% |
| Q2 2016 | $1,099,000 | +25.9% | 100,000 | 0.0% | 0.00% | +50.0% |
| Q1 2016 | $873,000 | – | 100,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,185,291 | $24,558,594 | 29.60% |
| EcoR1 Capital, LLC | 3,851,507 | $29,695,119 | 0.96% |
| ARMISTICE CAPITAL, LLC | 3,524,000 | $27,170,040 | 0.39% |
| EAM Investors, LLC | 123,818 | $954,637 | 0.19% |
| HARBOURVEST PARTNERS LLC | 61,776 | $476,293 | 0.16% |
| Diametric Capital, LP | 12,527 | $96,583 | 0.05% |
| Campbell & CO Investment Adviser LLC | 30,563 | $235,641 | 0.04% |
| CAXTON ASSOCIATES LP | 36,564 | $281,908 | 0.04% |
| FIDUCIARY TRUST CO | 252,303 | $1,945,256 | 0.04% |
| GLOBEFLEX CAPITAL L P | 36,109 | $278,400 | 0.03% |